Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective studyArticle Published on 2022-10-132022-11-15 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome administration anti-RBD antibody BNT-162b2 ChAdOx1 vaccine coronavirus coronavirus disease COVID-19 diabetes disease dose doses Effect Efficacy first dose IgG Immunity vaccine Immunoglobulin Infection kidney kidney transplant liver liver transplant Local no difference older patient Organ transplant Patient platform Primary outcome Prospective Study prospectively studied question recipient reduced resulting SARS-CoV-2 SARS-CoV-2 vaccination second dose secondary endpoint seroconversion rate shown side significantly solid organ transplant spread to systemic adverse event the RBD the spike protein the vaccine trials unresponsiveness vaccination Vaccine vaccine doses vaccine platform [DOI] 10.1186/s12879-022-07764-x PMC 바로가기
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic reviewArticle Published on 2022-10-132022-11-15 Journal: BMC Gastroenterology [Category] 진단, [키워드] article Autoimmune hepatitis benefit cellular CINAHL complications COVID-19 COVID-19 vaccination COVID-19 vaccines disease English language Evidence hepatic hepatic failure Hepatic porphyria Hepatitis hepatomegaly incidence include indicated item jaundice liver Liver disease liver enzyme Liver injury Meta Most patient Nature occur occurred offered Other pathology post-COVID-19 vaccination Protective raised rejection reported Reporting review Safety SARS-CoV-2 searched side Side effect systematic review therapy thrombosis treated vaccination Vaccine worldwide pandemic [DOI] 10.1186/s12876-022-02507-3 PMC 바로가기
Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccinationArticle Published on 2022-09-162022-11-15 Journal: Vaccine [Category] SARS, 진단, [키워드] acute respiratory syndrome age Analysis analyzed Anti-spike antibody antibody level Antibody titre BNT162b2 BNT162b2 vaccine Care conducted coronavirus disease coronavirus disease-2019 Coronavirus-2 COVID-19 decrease dose Factor female females healthcare healthcare worker Healthcare workers hospital IgG IgG antibody Japanese negative correlation participant Participants preserved Prospective Study Protein Regression SARS-CoV-2 side Side effects tested the vaccine vaccination were infected [DOI] 10.1016/j.vaccine.2022.08.035 PMC 바로가기
Outcomes of pregnant patients treated with REGEN-COV during the COVID-19 pandemicArticle Published on 2022-09-012022-10-05 Journal: American journal of obstetrics & gynecology MFM [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] administration Admission adverse events anaphylaxis Atlanta authorization benefit casirivimab and imdevimab Clinical course Clinical outcome Cohort cohort of patient COVID-19 COVID-19 illness COVID-19 pandemic COVID-19 therapeutics death drug Effect Efficacy eligible Emergency food groups high-risk population higher risk Hospital stay Hospitalization Hypothesis increased risk individual Infection instance intensive care less Maternal morbidity Memorial monoclonal antibodies monoclonal antibody morbidity and mortality need for oxygen Neonatal Neonatal morbidity no significant difference nonpregnant novel therapies offered outcome outcomes Oxygen requirement patients with SARS-CoV-2 pharmacologic treatment Placebo polymerase chain positive Pregnancy pregnant pregnant patient pregnant patients pregnant population receive reduce reduced REGEN-COV released resolved Respiratory illness retrospective cohort study risk Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 viral load severe COVID-19 severe disease Shortness of breath shown side statistically significant difference Symptom tested therapy thought treated Treatment treatment guideline Trial trials ventilatory support were excluded worsening [DOI] 10.1016/j.ajogmf.2022.100673 [Article Type] Article
Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose단일 메신저 RNA 백신 용량을 사용하여 SARS-CoV-2 감염 후 산모 및 신생아 체액성 면역 강화Article Published on 2022-09-012022-09-11 Journal: American journal of obstetrics and gynecology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Affect analyzed anti SARS-CoV-2 antibody anti-SARS-CoV-2 antibody antibody antibody levels approach BNT162b2 booster dose boosting vaccine dose Case-control case-control study collected consecutive sample convalescent Cord blood COVID-19 COVID-19 vaccination determined by dose during pregnancy Effect first trimester group Guidance Humoral immunity increase in Infection Jerusalem Messenger RNA Mild symptom mild symptoms moderate mother naïve Neonatal Newborn outcomes pandemic parturient patients polymerase chain polymerase chain reaction Postinfection postinfection vaccine Pregnancy proportion Protective reported robust SARS-CoV-2 SARS-COV-2 infection second trimester selected serum sample serum samples side Side effects single booster dose single dose Stage study groups tested Umbilical cord umbilical cord blood umbilical cords undetectable vaccination Vaccine vaccine dose vaccine during. was determined [DOI] 10.1016/j.ajog.2022.04.010 PMC 바로가기 [Article Type] Article
Managing an evolving pandemic: Cryptic circulation of the Delta variant during the Omicron rise진화하는 전염병 관리: 오미크론 상승 중 Delta 변종의 비밀 순환Article Published on 2022-08-252022-09-11 Journal: The Science of the total environment [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Chain Reaction Characteristics circulation decrease Delta delta variant diminishe dominant eliminated Epidemiology expected Increases indicated initial maintain managing morbidity Mutation omicron Omicron variant pandemic polymerase chain polymerase chain reaction Quantitative real time reverse transcriptase Reverse transcriptase quantitative polymerase chain reaction RT-qPCR SARS-CoV-2 side Spread Susceptible-infected-recovered model variant variants variants of concern Wastewater-based epidemiology [DOI] 10.1016/j.scitotenv.2022.155599 PMC 바로가기 [Article Type] Article
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineagesSARS-CoV-2 Omicron BA.1, BA.1.1, BA.2 및 BA.3 하위 계통의 항체 회피Article Published on 2022-08-102022-09-11 Journal: Cell Host & Microbe [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibody Antibody therapeutics antigenic approved BA.1 BA.1.1 BA.2 BA.3 BBIBP-CorV booster comparison dominant dose Efficacy highlighting homologous or heterologous IMPROVE inactivated individual lineages mAb mAbs monoclonal antibody MOST neutralization neutralization activity neutralization titer neutralization titers Neutralizing activity omicron profile pseudovirus reported SARS-CoV-2 sera side spike mutations Vaccine variant [DOI] 10.1016/j.chom.2022.05.001 PMC 바로가기 [Article Type] Article
Do Side Effects to the Primary COVID-19 Vaccine Reduce Intentions for a COVID-19 Vaccine Booster?1차 COVID-19 백신의 부작용이 COVID-19 백신 부스터에 대한 의도를 감소시키나요?Article Published on 2022-08-022022-09-11 Journal: Annals of behavioral medicine : a publication of t [Category] 변종, [키워드] Administered Analysis booster booster vaccination Booster vaccine conducted COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine dataset demographic factor demographic variable Effect headache Immunity indicated individual intensity Intention Intentions measure National nausea Occurrence pandemic platform positive predict predicted Prolific Psychological reactogenicity receive recruited reduce reduced Regression analyses regression analysis reported Research secondary side Side effect Side effects subsequent Trust vaccination vaccination intention Vaccine Vaccine development variable virus variants Worry [DOI] 10.1093/abm/kaac027 PMC 바로가기 [Article Type] Article
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study자가면역 신경계 장애 환자에서 mRNA SARS-CoV-2 백신에 대한 안전성 및 체액 반응의 차이: ANCOVAX 연구Article Published on 2022-08-012022-09-11 Journal: Journal of Neurology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 95% CI ANC anti-CD20 anti-SARS-CoV-2 anti-SARS-CoV-2 IgG Anti-spike antibody antibody levels Antibody Response Assessing Autoimmune Autoimmune neurological disorders BNT162b2 BNT162b2 vaccine Clinical practice condition Control difference dose Effect evaluated fingolimod humoral Humoral response IgG immune therapy immunotherapies Immunotherapy incidence increased risk IQR Local longitudinal study mAb median age mRNA mRNA vaccine mRNA vaccines mRNA-1273 mRNA-1273 vaccine Multiple multiple sclerosis neurological Neurological status not different of BNT162b2 Patient patients rate ratio Receptor binding domain reduced Relapse Safe SARS-CoV-2 SARS-CoV-2 vaccine Sars-Cov2-mRNA vaccine. second dose seroconversion rate side Side effects systemic reaction systemic reactions the antibody response Treatment vaccination Vaccine were assessed [DOI] 10.1007/s00415-022-11142-7 PMC 바로가기 [Article Type] Article
CoVITEST: A Fast and Reliable Method to Monitor Anti-SARS-CoV-2 Specific T Cells From Whole BloodCoVITEST: 전혈에서 Anti-SARS-CoV-2 특정 T 세포를 모니터링하는 빠르고 신뢰할 수 있는 방법Article Published on 2022-07-052022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] adjust antibodies Antibody detection automated Blood blood test can be used Cellular immune response cellular immunity cellular response comparable complex convalescent COVID-19 demonstrated determine diagnostic Donor ELISPOT Evidence explained gold gold standard healthy help house humoral immune response humoral immune responses IFN-γ IFN-γ ELISPOT immune protection immune responses Immune status IMPROVE individual less MONITOR pandemic Patient protocol Reinfection SARS-CoV-2 side simple Specific Support T cell T cells Test therapeutic approaches vulnerable patient vulnerable patients weakened immune system [DOI] 10.3389/fimmu.2022.848586 PMC 바로가기 [Article Type] Article